Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage

References

• Morgan TM, Barocas DA, Chang SS, Phillips SE, Salem S, Clark PE, et al. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol 2013;31:871–7.
   PubMed Web of Science ®Google Scholar
• Kluth LA, Xylinas E, Rieken M, El Ghouayel M, Sun M, Karakiewicz PI, et al. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. BJU Int 2014;113:393–8.
   PubMed Web of Science ®Google Scholar
• Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839–45.
   PubMed Web of Science ®Google Scholar
• Gierth M, Aziz A, Fritsche HM, Burger M, Otto W, Zeman F, et al. The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder. World J Urol 2014;32:1447–53.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. Jama 2002;288:1499–507.
   PubMed Web of Science ®Google Scholar
• Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT Study: Anemia and blood transfusion in the critically ill – current clinical practice in the United States. Crit Care Med 2004;32:39–52.
   PubMed Web of Science ®Google Scholar
• Sutton JM, Kooby DA, Wilson GC, Squires MH, Hanseman DJ, Maithel SK, et al. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg 2014;18:1575–87.
   PubMed Web of Science ®Google Scholar
• Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 2012;256:235–44.
   PubMed Web of Science ®Google Scholar
• Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007;21:327–48.
   PubMed Web of Science ®Google Scholar
• Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013;110:690–701.
   PubMed Web of Science ®Google Scholar
• Boehm K, Beyer B, Tennstedt P, Schiffmann J, Budaeus L, Haese A, et al. No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer. World J Urol 2015;33:801–6.
   PubMed Web of Science ®Google Scholar
• Chalfin HJ, Frank SM, Feng Z, Trock BJ, Drake CG, Partin AW, et al. Allogeneic versus autologous blood transfusion and survival after radical prostatectomy. Transfusion 2014;54:2168–74.
   PubMed Web of Science ®Google Scholar
• Yeoh TY, Scavonetto F, Weingarten TN, Karnes RJ, van Buskirk CM, Hanson AC, et al. Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy. Transfusion 2014;54:2175–81.
   PubMed Web of Science ®Google Scholar
• Jakobsen EB, Eickhoff JH, Andersen JP, Ottesen M. Perioperative blood transfusion does not affect survival after operation for renal cell cancer. Eur Urol 1994;26:145–8.
   PubMed Web of Science ®Google Scholar
• Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). BJU Int 2014;114:368–74.
   PubMed Web of Science ®Google Scholar
• Sadeghi N, Badalato GM, Hruby G, Kates M, McKiernan JM. The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma. Can J Urol 2012;19:6443–9.
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim HS, Jeong CW, Kwak C, Kim HH, Ku JH. The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy. Korean J Urol 2015;56:295–304.
   PubMedGoogle Scholar
• Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008;36:2667–74.
   PubMed Web of Science ®Google Scholar
• Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012;157:49–58.
   PubMed Web of Science ®Google Scholar
• Rawn J. The silent risks of blood transfusion. Curr Opin Anaesthesiol 2008;21:664–8.
   PubMed Web of Science ®Google Scholar
• Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, et al. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol 2014;66:1139–47.
   PubMed Web of Science ®Google Scholar
• Grimm T, Buchner A, Schneevoigt B, Kretschmer A, Apfelbeck M, Grabbert M, et al. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study. World J Urol 2016;34:703–8.
   PubMed Web of Science ®Google Scholar
• Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372–6.
   PubMed Web of Science ®Google Scholar
• Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859–67.
   PubMed Web of Science ®Google Scholar
• Houbiers JG, Brand A, van de Watering LM, Hermans J, Verwey PJ, Bijnen AB, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573–8.
   PubMed Web of Science ®Google Scholar
• Upile T, Jerjes W, Mahil J, Sudhoff H, Hopper C, Wright A. Blood product transfusion and cancer prognosis. Clin Adv Hematol Oncol 2009;7:656–61.
   PubMedGoogle Scholar
• Monk TG, Goodnough LT. Blood conservation strategies to minimize allogeneic blood use in urologic surgery. Am J Surg 1995;170:69S–73S.
   PubMed Web of Science ®Google Scholar
• Karl A, Buchner A, Becker A, Staehler M, Seitz M, Khoder W, et al. A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol 2014;191:335–40.
   PubMed Web of Science ®Google Scholar